CB-103 is a first-in-class, orally active inhibitor of the Notch transcription activation complex. CB-103 inhibits Notch signaling in primary human T cell acute lymphoblastic leukemia and other Notch-dependent human tumor cell lines, and concomitantly in
Molecular Weight:
242.32
Purity:
>99%
CAS Number:
[218457-67-1]
Formula:
C15H18N2O
Target:
Notch
* VAT and and shipping costs not included. Errors and price changes excepted
